Catheter Precision terminates ATM equity facility after selling ~$4.0M of $4.3M

Catheter Precision, Inc.

Terminated ATM agreement with Ladenburg Thalmann effective November 24, 2025; no penalties.
Prior to termination, $4.0M of common stock sold under the $4.3M capacity.
Remaining $0.3M of at-the-market offering capacity is no longer available.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Catheter Precision, Inc. terminated At-Market-Offering Agreement with Ladenburg Thalmann & Co. Inc. (effective 2025-11-17).

Action: termination
Agreement: atm program
Counterparty: Ladenburg Thalmann & Co. Inc.
Effective: 2025-11-17

Exact text from the filing

On November 17, 2025, Catheter Precision, Inc. (the “Company”) delivered notice to terminate its At-Market-Offering Agreement (the “ATM Agreement”), dated as of May 19, 2025, with Ladenburg Thalmann & Co. Inc. (the “Agent”) providing for the Company’s “at‐the‐market” equity offering program (the “ATM Program”), to be effective as of November 24, 2025.

View on SEC.gov

272 material agreements filed in the last 30 days. Browse all material agreements →

Catheter Precision, Inc. filing history →

Source: SEC EDGAR

accession 0001437749-25-036000

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.